Americans are proving slow to follow the CDC’s advice to get a COVID-19 booster shot this fall. On Sept. 12, the CDC ...
The resizing, which resulted in $1.4 billion in charges during the third quarter, aims to make the company's Covid vaccine profitable in 2024 and beyond, Moderna CEO Stéphane Bancel said in a ...
which should increase the number of people that get a Covid vaccine over time because it's much more easy from a convenience ...
Moderna booked $3.1 billion in charges tied to excess Covid-19 vaccine doses and other costs last quarter. (fred tanneau/Agence France-Presse/Getty Images) Moderna (MRNA) swung to a loss and ...
Novavax Inc. could now get its Covid-19 vaccine to nearly 200 more countries. It’s a critical win in the company’s bid to get ...
Moderna Inc (NASDAQ: MRNA) shares slipped on Tuesday trading after the European Patent Office said a contested mRNA patent ...
Moderna’s vaccine sales during ... 25 and the combination of COVID sales in the endemic setting, we believe Moderna will be in sales growth again in 2025,” said CEO Stéphane Bancel on an ...
Moderna's COVID-19 vaccine is its lone marketed product. TD Cowen analyst Tyler Van Buren in a research note said he is not convinced Moderna's full-year expectations for the overall market is ...
Moderna posted a quarterly loss of $3.63 billion on Thursday, half of which was accounted for by unused Covid-19 shots exceeding their expiration date. Moderna isn't the only Covid vaccine maker ...
News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine manufacturers' stock prices to rise Monday. Moderna CEO ...
And because Novavax’s product became available a few weeks later than the mRNA vaccines from Pfizer-BioNtech and Moderna ... Novavax’s Covid vaccine lands EU approval CEO John Jacobs has ...
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced the presentation of data from the active ...